SEPTEMBER 24th
10:00 am - 4:00 pm
SCIENCE
DAY 2018
1
PULMONARY ARTERIAL HYPERTENSION (PAH) STATE OF THE SCIENCE
2
TREPROSTINIL IS VERSATILE
3
THE BEAT COMBINATION STUDY
4
TREVYENT® PARENTERAL TREPROSTINIL SODIUM
5
TECHNOSPHERE® Drug Delivery Platform
6
RESTORATIVE MEDICINE PLATFORM FOR: Degenerative Diseases…
7
THE SAPPHIRE STUDY / Progenitor NO Corundum
8
THE SOUTHPAW STUDY / Heart Failure and Preserved…
9
THE iTRE STUDY / Therapeutic Opportunity for Inhaled…
10
THE INCREASE STUDY / Inhaled Treprostinil in Pulmonary…
11
THE PERFECT STUDY / Pulmonary Hypertension (PH)…
12
ORGAN MANUFACTURING / The Vision to a Cure with…
13
2018 Morning session webcast
14
2018 Afternoon session webcast
1
| PULMONARY ARTERIAL HYPERTENSION (PAH)
STATE OF THE SCIENCE
Victor F. Tapson,
MD, FCCP, FRCP
Pulmonary/Critical Care Division, Cedars-Sinai Medical Center, Los Angeles, CA USA
2
| TREPROSTINIL IS VERSATILE
Leigh Peterson,
PhD
Vice President, Product Development, United Therapeutics Corporation
3
| THE BEAT COMBINATION STUDY
4
| TREVYENT®
Parenteral Treprostinil Sodium
5
| TECHNOSPHERE®
Drug Delivery Platform
6
| RESTORATIVE MEDICINE PLATFORM FOR:
Degenerative Diseases, Oncology and Other Proliferative Indications, and Inflammatory Conditions
7
| THE SAPPHIRE STUDY
Progenitor NO Corundum
8
| THE SOUTHPAW STUDY
Heart Failure and Preserved Ejection Fraction: Clinical Study Design and Treatment
Mardi Gomberg-Maitland,
MD, MSc
Professor of Medicine, Inova Heart and Vascular Institute, VA USA
9
| THE iTRE STUDY
Therapeutic Opportunity for Inhaled Treprostinil in Patients with PH Secondary to Primary Pulmonary Vascular Disease
Aaron B. Waxman,
MD, PhD, FACP, FCCP
Pulmonary and Critical Care Medicine, Director, Pulmonary Vascular Disease Program, Executive Director, Center for Pulmonary-Heart Diseases, Brigham and Women’s Hospital Heart and Vascular Center; Associate Professor of Medicine, Harvard Medical School
10
| THE INCREASE STUDY
Inhaled Treprostinil in Pulmonary Hypertension Due to Interstitial Lung Disease (PH-ILD)
Peter Smith,
PharmD
Senior Director, Product Development, United Therapeutics Corporation
11
| THE PERFECT STUDY
Pulmonary Hypertension (PH) Enrichment Study for Evaluation of COPD with Inhaled Treprostinil
Aaron B. Waxman,
MD, PhD, FACP, FCCP
Pulmonary and Critical Care Medicine, Director, Pulmonary Vascular Disease Program, Executive Director, Center for Pulmonary-Heart Diseases, Brigham and Women’s Hospital Heart and Vascular Center; Associate Professor of Medicine, Harvard Medical School
12
| ORGAN MANUFACTURING
The Vision to a Cure with an Unlimited Supply of Organs
Martine Rothblatt,
PhD
Chairman and Chief Executive Officer, United Therapeutics Corporation
13
| 2018 MORNING SESSION WEBCAST
14
| 2018 AFTERNOON SESSION WEBCAST